Publications by Margaret-Ann Tait

Journals

  • Wiltink L, King MT, Müller F, Sousa M, Tang M, Pendlebury A, Pittman J, Roberts N, Mileshkin L, Mercieca-Bebber R, Tait M, Campbell R, Rutherford C. A systematic review of the impact of contemporary treatment modalities for cervical cancer on women’s self-reported health-related quality of life. Supportive Care in Cancer, accepted 25/05/2020.
  • Mercieca-Bebber R, Williams D, Tait M, Rutherford C, Busija L, Roberts N, Wilson M, Sundaram CS, Roydhouse JK, on behalf of the International Society for Patient-Reported Outcomes Research (ISOQOL) (2018) Trials with proxy-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR). Quality of Life Research, online first https://doi.org/10.1007/s11136-018-2080-4.
  • Mercieca-Bebber R, Williams D, Tait M, Roydhouse JK, Sundaram CS, Wilson M, Langford A, Busija L, Rutherford C, Roberts N, King M, Vodicka E, Devine B, on behalf of the International Society for Patient-Reported Outcomes Research (ISOQOL) (2018) Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR). Quality of Life Research, 27(10): 2581-91. https://doi.org/10.1007/s11136-018-1921-5
  • Rutherford C, Patel M, Tait M, Smith D, Costa D, King M (2018) Assessment of content validity for patient-reported outcome measures used in patients with non-muscle invasive bladder cancer: a systematic review. Supportive Care in Cancer, 26(4):1061-1076. http://rdcu.be/F6mF
  • Rutherford C, King M, Smith D, Costa D, Tait M, Patel M on behalf of the NMIBC-SI Working Group (2017) Psychometric evaluation of a patient-reported Symptom Index for non-muscle invasive bladder cancer: field testing Protocol. JMIR Research Protocols, 6(11):e216.

Book Chapters

  • Campbell R, King MT, Lee YC, Mileshkin L, Tait M, Rutherford C (2019) Quality of life in women with ovarian cancer. In Farghaly S (editor) Advances in Diagnosis and Management of Ovarian Cancer, 2nd ed. New York: Springer.
  • Rutherford C, Mercieca-Bebber R, Tait M, Sullivan L, Mileshkin L, King M (2018) Quality of life in women with endometrial cancer. In: Farghaly S (editor) Endometrial Cancer: Current Epidemiology, Detection, and management (Second Edition). New York: Nova Science Publishers.
  • Rutherford C, Mercieca-Bebber R, Tait M, Mileshkin L, King M (2017) Quality of life in cervical cancer. In: Farghaly S (editor) Uterine Cervical Cancer: Clinical and Therapeautic Perspectives. New York: Springer. DOI: 10.1007/978-3-030-02701-8 [ISBN ( Print): 978-3-030-02700-1; ISBN ( EBook): 978-3-030-02700-1]

Under review

  • Costa SDJ, Mercieca-Bebber R, Rutherford C, Tait M, King MT. How is quality of life defined and assessed in published research? Quality of Life Research, submitted 28/12/2019.
  • Rutherford C, Patel MI, Tait M, Smith DP, Costa DSJ, Sengupta S, King MT. Patient-reported outcomes in non-muscle invasive bladder cancer: a mixed methods systematic review. Quality of Life Research, submitted 06/03/2020.
  • Wiltink L, King MT, Tait M, Butow P, Spillane A, Boxer MM, Winters Z, McPherson J, Rutherford C. Clinicians’ attitudes towards communication, treatment decision making and use of decision aids in ductal carcinoma in situ. Breast Cancer Research and Treatment Journal, submitted May 2020.

Conference Abstracts

  • Rutherford C, Tait M, Costa DSJ, King MT, Smith DP, Sengupta S, Patel M, on behalf of the NMIBC-SI Study Group. Development of a patient-reported symptom index for use with non-muscle invasive bladder cancer patients using mixed methods. American Urological Association’s (AUA) 2020 Annual Meeting, Washington DC 15 – 19 May, 2020.
  • Rutherford C, Tait M, Costa DSJ, King MT, Smith DP, Sengupta S, Patel M, on behalf of the NMIBC-SI Study Group. Mixed methods to develop and evaluate a patient-reported symptom index for use with non-muscle invasive bladder cancer patients, Clinical Oncology Society of Australia (COSA), Annual Scientific Meeting, Adelaide 12 – 14 November 2019 (Oral).
  • Campbell R, Müller F, Tait M, Rutherford C, Mercieca-Bebber R, King MT, Improving the PRO content of clinical trial protocols: Implementation of the SPIRIT-PRO through educational workshops, International Society for Quality of Life Research (ISOQOL), Annual Scientific Meeting, San Diego, USA, 22 October, 2019.
  • Rutherford C, Tait M, Butow P, King MT, Decision Support Tools (DSTs) for patients diagnosed with ductal carcinoma in situ (DCIS): systematic review of the literature and web, The International Psycho-Oncology Society, 20th World Congress, Hong Kong 29 October 2018 (Poster).
  • Rutherford C, King M, Smith DP, Costa DSJ, Tait M, Patel MI, New patient-reported symptom index for use with non-muscle invasive bladder cancer patients in clinical trials. Presented at the USANZ 71st ASM including the ANZUNS 23rd Annual Meeting, Melbourne 24-27 February 2018. BJUI, 121(S1):84.
  • Mercieca-Bebber R, Langford A, Rutherford C, Busija L, Tinsley M, Roberts N, Roydhouse JK, Wilson M, Tait M, King M, Vodicka E, Devine B. A systematic scoping review of the Australian New Zealand Clinical Trials Registry for trials with patient-reported outcome and proxy-rated endpoints. Quality of Life Research 2017; 26(Suppl 1): 3052.
  • Rutherford C, Mercieca-Bebber R, Spillane A, Boxer M, Winters Z, Butow P, McPherson J, Tait M, King M. Patient-reported outcomes rarely inform international clinical practice guideline recommendations or treatment decision-making in early breast cancer. Presented at International Society for Quality of Life Research (ISOQOL), Annual Scientific Meeting, Copenhagen, Denmark 19-21 October 2016 (Oral).
  • Symposium: Rutherford C, Butow P, Spillane A, Boxer M, McPherson J, Winters Z, Mercieca-Bebber R, Tait M, King M. Towards the development of a patient decision aid for women with ductal carcinoma in situ of the breast. Presented at Clinical Oncology Society of Australia (COSA), Annual Scientific Meeting, Gold Coast, Nov 2016 (Oral).
  • Rutherford C,  Mercieca-Bebber R, Spillane A, Boxer M, Winters Z, Butow P, McPherson J, Tait M, King MT. International clinical practice guidelines for Ductal carcinoma in situ and early breast cancer are outdated and rarely informed by quality of life outcomes. Presented at The 8th Leura International Breast Cancer Conference, Leura, Oct 2016 (Poster).
  • Rutherford C,  Mercieca-Bebber R, Spillane A, Boxer M, Winters Z, Butow P, McPherson J, Tait M, King MT. International clinical guidelines for early breast cancer are outdated and not informed by QOL outcomes. Presented at Sydney Cancer Conference, Sydney, Sep 2016 (Poster).

Other